NCT03342027View on ClinicalTrials.gov

Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

July 25, 2023

Study Completion Date

July 25, 2023

Conditions
HIVSmoking Cessation
Interventions
DRUG

Bupropion

medication for smoking cessation

BEHAVIORAL

Positively smoke free

an 8 session, tailored behavioral intervention for treating tobacco dependence

OTHER

Brief advice to quit smoking

Standardized brief advice to quit smoking (standard of care)

Trial Locations (1)

Unknown

Center for International Health, Education, and Biosecurity (CIHEB), Kilimani

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT03342027 - Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya | Biotech Hunter | Biotech Hunter